Helixmith ranked among the top searched stocks on 6 days within the past month.
As of 2:30 PM on the 21st, Helixmith is trading at 20,250 KRW, up 3.32% from the previous day. This is a 61.21% decrease compared to September 17. Helixmith is known as a company specializing in new drug development focused on gene therapy.
Today, foreign investors are tentatively recorded as net sellers of 33,000 shares. Over the past 5 days, individual investors have net purchased 126,514 shares, while foreign and institutional investors have net purchased 111,548 shares and net sold 194,984 shares, respectively.
On October 20, Helixmith became an issue in the market with headlines such as "Continuous sharp decline due to private equity fund losses."


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![User Who Sold Erroneously Deposited Bitcoins to Repay Debt and Fund Entertainment... What Did the Supreme Court Decide in 2021? [Legal Issue Check]](https://cwcontent.asiae.co.kr/asiaresize/183/2026020910431234020_1770601391.png)
